NYP-Named-One-of-the-Best-Places-to-Work-in-2019-by-Glassdoor
NewYork-Presbyterian Hospital has been recognized by Glassdoor as one of the Best Places to Work in 2019. NewYork-Presbyterian was the top-ranked hospital in New York and ranked third nationally among hospital systems that made the list.
Dr-Hidalgo-Named-Chief-Hematology-and-Medical-Oncology-WCM-NYPWC
Dr. Manuel Hidalgo, a leading physician-scientist who specializes in pancreatic cancer and drug development, has been named chief of the Division of Hematology and Medical Oncology in the Weill Department of Medicine at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, effective June 1. Dr. Hidalgo will also serve on the leadership team at the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine.
New-Smart-Drug-for-Metastatic-Triple-Negative-Breast-Cancer
A clinical trial at NewYork-Presbyterian/Columbia and other centers found that patients responded to a new “smart drug” for women with an aggressive form of breast cancer.
NYP-Splunk-Implement-New-Approach-to-Guard-Against-Opioid-Misuse
Splunk Inc. (NASDAQ: SPLK), delivering actions and outcomes from the world of data, and NewYork-Presbyterian, one of the nation’s most comprehensive academic healthcare delivery systems, are collaborating to help solve one of the toughest challenges in healthcare.
NYP-Wins-Two-Best-and-Brightest-Awards-2019
NewYork-Presbyterian Hospital recently won two Best and Brightest awards from the National Association for Business Resources (NABR). In 2018, NewYork-Presbyterian Hospital was recognized as one of the Best and Brightest Companies to Work For and was among the Best and Brightest in Wellness.
Immunotherapy-May-Help-Patients-with-Advanced-Esophageal-Cancer
Treating patients with advanced, metastatic esophageal cancer with an immune-system boosting drug called pembrolizumab, known by its brand name Keytruda, led to regression of tumors in some patients, according to results of a phase 2 clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators.
Hepatitis-Common-in-New-Cancer-Patients
A multicenter study from SWOG Cancer Research Network found that infections with hepatitis B and C are common in new cancer patients, but few of these patients are screened for these viruses.
NewYork-Presbyterian-Hospital-Expands-Virtual-Care-with-Philips
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that NewYork-Presbyterian Hospital will expand its telehealth capabilities with Philips remote patient monitoring.
Page50 of 168